Joseph Markowitz

10PUBLICATIONS
43CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Formal methods for softwareMechanobiologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 14, 2026
Neoadjuvant lenvatinib plus pembrolizumab in Merkel cell carcinoma: an investigator-initiated, open-label phase II trial.

Andrew S Brohl, Vernon K Sondak, Evan J Wuthrick

|Mar 06, 2025
Phase II Trial of Pembrolizumab in Combination With Bevacizumab for Untreated Melanoma Brain Metastases.

Sarah A Weiss, Dijana Djureinovic, Wei Wei

|Dec 05, 2024
spatialGE Is a User-Friendly Web Application That Facilitates Spatial Transcriptomics Data Analysis.

Oscar E Ospina, Roberto Manjarres-Betancur, Guillermo Gonzalez-Calderon

|Sep 06, 2024
Durability of response to immune checkpoint blockade following treatment discontinuation and efficacy of rechallenge in advanced Merkel cell carcinoma.

Tanya Ramadoss, Matthew Nichols, Christian Palacios

|Jul 15, 2024
spatialGE: A user-friendly web application to democratize spatial transcriptomics analysis.

Oscar E Ospina, Roberto Manjarres-Betancur, Guillermo Gonzalez-Calderon

|Apr 24, 2024
First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0.

Joseph Markowitz, Michael Shamblott, Andrew S Brohl

Pageof 2